Fidelity Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Buy
173,993
+33,433
+24% +$726K ﹤0.01% 2369
2025
Q4
$2.95M Buy
140,560
+135,459
+2,656% +$2.36M ﹤0.01% 2463
2025
Q3
$78.5K Sell
5,101
-155,817
-97% -$2.04M ﹤0.01% 3766
2025
Q2
$1.51M Buy
160,918
+38,660
+32% +$426K ﹤0.01% 2587
2025
Q1
$1.5M Buy
122,258
+37,057
+43% +$523K ﹤0.01% 2537
2024
Q4
$1.13M Buy
85,201
+35,953
+73% +$615K ﹤0.01% 2629
2024
Q3
$948K Buy
49,248
+12,377
+34% +$256K ﹤0.01% 2616
2024
Q2
$757K Buy
36,871
+2,801
+8% +$58.6K ﹤0.01% 2604
2024
Q1
$811K Sell
34,070
-6,626
-16% -$148K ﹤0.01% 2571
2023
Q4
$879K Sell
40,696
-3,286
-7% -$50.5K ﹤0.01% 2510
2023
Q3
$639K Buy
43,982
+2,237
+5% +$42.3K ﹤0.01% 2570
2023
Q2
$874K Buy
41,745
+204
+0.5% +$4.25K ﹤0.01% 2505
2023
Q1
$877K Buy
41,541
+317
+0.8% +$7.88K ﹤0.01% 2549
2022
Q4
$1.05M Sell
41,224
-124,649
-75% -$2.91M ﹤0.01% 2528
2022
Q3
$3.99M Buy
165,873
+40,217
+32% +$902K ﹤0.01% 2237
2022
Q2
$2.42M Sell
125,656
-63,087
-33% -$1.05M ﹤0.01% 2447
2022
Q1
$3.28M Buy
188,743
+1,394
+0.7% +$23.5K ﹤0.01% 2475
2021
Q4
$4.1M Buy
+187,349
New +$3.46M ﹤0.01% 2409
2018
Q4
Sell
-348,653
Closed -$2.82M 4099
2018
Q3
$2.82M Sell
348,653
-211,549
-38% -$1.51M ﹤0.01% 2297
2018
Q2
$3.93M Hold
560,202
﹤0.01% 2206
2018
Q1
$7.97M Sell
560,202
-142,642
-20% -$1.51M ﹤0.01% 2019
2017
Q4
$6.16M Sell
702,844
-394,707
-36% -$3.91M ﹤0.01% 2108
2017
Q3
$12.8M Sell
1,097,551
-244,093
-18% -$2.99M ﹤0.01% 1856
2017
Q2
$18.7M Buy
1,341,644
+91,328
+7% +$1.04M ﹤0.01% 1701
2017
Q1
$17.2M Sell
1,250,316
-229,731
-16% -$2.39M ﹤0.01% 1751
2016
Q4
$10.6M Sell
1,480,047
-614,417
-29% -$6.73M ﹤0.01% 1946
2016
Q3
$31.8M Hold
2,094,464
﹤0.01% 1484
2016
Q2
$20.6M Hold
2,094,464
﹤0.01% 1665
2016
Q1
$27.9M Buy
+2,094,464
New +$26.3M ﹤0.01% 1507

Other funds holding SNDX